ANDA 65516, held by Aurobindo Pharma Ltd. Cefotaxime Sodium.
As of Nov 16, 2026, ANDA 65516 (Cefotaxime Sodium), held by Aurobindo Pharma Ltd, was first approved by FDA on Nov 5, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 5, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cefotaxime SodiumEQ 10GM BASE/VIAL ยท injectable;injection | Cefotaxime Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters